Study of Ayurvedic drug Calciactiv for the treatment of bone weakness

Clinical evaluation of efficacy and safety of Calciactiv in Osteopenia and Osteoporosis- An Observational Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/08/009259

Enrollment

Registered

2017-08-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture Health Condition 2: null- Osteopenia, Osteoporosis, Decreased Bone Density

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients (age 18 â?? 65 years) of either sex 2. Clinical symptoms of osteopenia and osteoporosis (bone pain, joint pain, frequent fractures etc.)

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study 2. Patients with complicating comorbid conditions like cardiac disorders, uncontrolled diabetes, renal impairment, hepatic impairment etc. 3. Patients with severe osteoporosis due to chemotherapy or as a complication of other concurrent treatments.

Design outcomes

Primary

Measure	Time frame
Evaluation of efficacy of Calciactiv using improvement in clinical symptoms of osteopenia and osteoporosis and Bone density testing using peripheral Dual energy x-ray absorptiometry (DXA).Timepoint: 0 days, 15 days, 30 days	—

Secondary

Measure	Time frame
Evaluation of safety and tolerability of Calciactiv by recording and assessing causality of adverse events during the study.Timepoint: 15 days, 30 days	—

Countries

India

Contacts

Public ContactDr Omkar Kulkarni

Samshodhanam Healthcare Research Services

vedaratnaayurved@gmail.com9922435119

Outcome results